Boston Scientific Corp. won a nod from the FDA to market its Spectra Wavewriter spinal cord stimulator (SCS) system to treat pain. The Marlborough, Mass.-based company said its SCS works by sending ...

Boston ScientificBSX is hitting headlines with successive new developments, the latest feat being the company's Spectra WaveWriter Spinal Cord Stimulator System (SCS) getting an FDA nod. Per Boston ...

The FDA gave the green light to Boston Scientific’s first-of-its-kind electric pulse system designed to treat pain without the use of opioids. Dubbed the Spectra WaveWriter, the spinal cord stimulator ...

The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...

System offers multiple non-drug therapies for people with chronic pain PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra ...

The FDA approved Boston Scientific's Spectra WaveWriter Spinal Cord Stimulator System. Here's what you should know: 1. The system is the first and only FDA-approved system that simultaneously provides ...

Boston Scientific announced Thursday it has received regulatory approval for a new treatment for chronic pain without the use of opioids. The product, the Spectra WaveWriter Spinal Cord Stimulator ...